Financial reports
10-Q
2023 Q1
Quarterly report
3 May 23
10-K/A
2022 FY
Annual report (amended)
20 Apr 23
10-K
2022 FY
Annual report
22 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
22 Feb 22
10-Q
2021 Q3
Quarterly report
3 Nov 21
10-Q
2021 Q2
Quarterly report
4 Aug 21
10-Q
2021 Q1
Quarterly report
3 May 21
Current reports
8-K
U.S. Private Equity Firm Advent International and BCI Complete Acquisition of Maxar Technologies
3 May 23
8-K
Maxar Technologies Stockholders Approve Acquisition by Advent International
20 Apr 23
8-K
Maxar Technologies Provides Update on Status of Regulatory Approvals of Proposed Acquisition by Advent International
14 Apr 23
8-K
Other Events
11 Apr 23
8-K
Maxar Board of Directors Approves Quarterly Dividend
1 Mar 23
8-K
Maxar Technologies Announces Completion of “Go-Shop” Period
15 Feb 23
8-K
Maxar Technologies to Be Acquired by Advent International for $6.4 Billion
16 Dec 22
8-K
Regulation FD Disclosure
30 Nov 22
8-K
Regulation FD Disclosure
22 Nov 22
8-K
Maxar Technologies Reports Third Quarter 2022 Results
3 Nov 22
Registration and prospectus
15-12G
Securities registration termination
15 May 23
25-NSE
Exchange delisting
3 May 23
25-NSE
Exchange delisting
3 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
3 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
3 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
3 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
3 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
3 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
3 May 23
POS AM
Prospectus update (post-effective amendment)
3 May 23
Proxies
DEFA14A
Additional proxy soliciting materials
14 Apr 23
DEFA14A
Additional proxy soliciting materials
11 Apr 23
DEFM14A
Proxy related to merger
16 Mar 23
DEFA14A
Additional proxy soliciting materials
15 Feb 23
DEFA14A
Additional proxy soliciting materials
15 Feb 23
PREM14A
Preliminary proxy related to merger
31 Jan 23
DEFA14A
Additional proxy soliciting materials
16 Dec 22
DEFA14A
Additional proxy soliciting materials
16 Dec 22
DEFA14A
Additional proxy soliciting materials
16 Dec 22
DEFA14A
Additional proxy soliciting materials
31 Mar 22
Other
EFFECT
Notice of effectiveness
4 May 23
UPLOAD
Letter from SEC
13 Mar 23
CORRESP
Correspondence with SEC
21 Feb 23
UPLOAD
Letter from SEC
14 Feb 23
CT ORDER
Confidential treatment order
1 Sep 20
SEC STAFF
SEC staff action: Order
18 Feb 20
SEC STAFF
SEC staff action: Order
4 Feb 20
CT ORDER
Confidential treatment order
27 Mar 19
CERTNYS
Certification of approval for NYSE listing
3 Oct 17
CT ORDER
Confidential treatment order
19 Jun 17